Business UpdateMay 18, 2026, 08:37 AM

Kairos Pharma Issues Investor Presentation, CEO to Present at LD Micro

AI Summary

Kairos Pharma, Ltd. announced the issuance of a new investor presentation on May 18, 2026. The presentation will be available on the company's website and will be delivered by CEO John Yu at the 2026 LD Micro Invitational XVI in Los Angeles. The presentation aims to provide updates on the company's clinical program and partnering activities.

Key Highlights

Kairos Pharma issued a new investor presentation on May 18, 2026.
The presentation will be published on the company's website.
CEO John Yu will present the investor presentation at the 2026 LD Micro Invitational XVI.
The LD Micro Invitational is taking place in Los Angeles, CA from May 18-19, 2026.
The presentation will update on the company's clinical program and partnering activities.

View SEC Filing

KAPA

Pharmaceutical Preparations

Kairos Pharma, LTD.

Price Impact